USPTO serial 79322244
REGENHU
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Aug 15, 2023
- Examiner
- BETTS, MARCYA
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.
Need help with REGENHU?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Brian P. Sullivan
Brian P. Sullivan Thomas E. Lees, LLC90 Rhoads Center DriveDayton, OH 45458UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | Chemical, biochemical and biological products, namely, unprocessed natural and synthetic polymers, hydrogels being cellulose for industrial purposes and collagen for industrial purposes, weak and strong gels being Polyethylene glycol, synthetic unprocessed resins, pastes being silicone fluids, degreasing solvents, liquid carriers being cell culture media, chemical additives improving ink printability, plasticizers, biochemicals, unprocessed growth factors, thermoplastic polymers, chemical composites, metallic and ceramic micro and nanoparticles being calcium phosphates, graphene, iron oxide, and silica particles, biological molecules being enzymes and peptides, active pharmaceutical ingredients and cell culture media for laboratory use, all for use in the manufacture and production of biological tissues; ink for 3D printing of biological tissues and organs; biologically compatible materials, namely, hydrogels used to create structures and scaffolds used in the manufacture and production of biological tissues; biologically compatible materials, namely, hydrogels used to create polymer arrays for scientific and medical research used in the manufacture and production of biological tissues; cell culture media, reagents for scientific or medical research use for use with biological tissues, tissue arrays, cell aggregates and cells; biological tissue samples being biological tissue cultures, biological tissue-engineered tissues being biological tissue cultures, tissue arrays, cell aggregates and cells for scientific research purpose; liquid photosensitive chemicals and resin products, namely, photoinitiators for use in the manufacture of 3D objects; solid imaging materials used to create 3D objects, namely, photocurable unprocessed polymers, unprocessed powder polymers and plastic molding compounds used in the manufacture of 3D objects; unprocessed polymers and unprocessed artificial resins for additive manufacturing of crowns, being dental inlays and onlays, and dental implants | ACTIVE | — |
| 005 | ATMPs (Advanced Therapy Medicinal Products), namely, medicines for human use based on genes, tissues or cells for the treatment of cancer, degenerative diseases, bacterial infections, viral infections, autoimmune diseases, and traumatic injuries; biological tissues, namely, bone, cartilage, skin, blood vessel, neural, muscular, heart, adipose, ocular, liver, pancreatic, and gut tissues and biological organ tissue manufactured for medical and transplant purposes; biological tissue samples being biological tissue cultures, biological tissue-engineered tissues being biological tissue cultures, tissue compositions being biological tissue grafts, cell aggregates and cells intended for medical use for medical applications; medical implants comprising living bioactives, biological cells or tissues; biological preparations for the treatment of cancer, degenerative diseases, bacterial infections, viral infections, autoimmune diseases, and traumatic injuries and biological tissue cultures for medical purposes; biological preparations for the treatment of cancer, degenerative diseases, bacterial infections, viral infections, autoimmune diseases, and traumatic injuries and biological tissue cultures for veterinary purposes; pharmaceutical products for the treatment of cancer, degenerative diseases, bacterial infections, viral infections, autoimmune diseases, and traumatic injuries; tissue-regenerative pharmaceutical preparations for prevention and treatment of cancer, degenerative diseases, bacterial infections, viral infections, autoimmune diseases, and traumatic injuries; medicines and gel capsules for medical use for the treatment of cancer, degenerative diseases, bacterial infections, viral infections, autoimmune diseases, and traumatic injuries; biological implants for surgical and orthopedic purposes, namely, bone, cartilage, skin, blood vessel, neural, muscular, heart, adipose, ocular, liver, pancreatic, gut, and biological organ tissue intended for subsequent implantation | ACTIVE | — |
| 007 | Machines and their parts and equipment, namely, 3D printers, 3D bioprinters, handling apparatus for loading and unloading in the nature of loading and unloading machines, and automatic handling machine, all for manufacturing and producing biological tissues and organs, medical implants, pharmaceuticals; machines and instruments, namely, 3D printers, 3D bioprinters, handling apparatus for loading and unloading in the nature of loading and unloading machines, and automatic handling machine, all for manufacturing and assembling biological tissues, tissue compositions, cell aggregates and cells; additive manufacturing machines for manufacturing and producing 3D objects; extruders, namely, extruding machines for microextrusion, multi-axial extrusion, droplet extrusion, micro-fiber extrusion, patterning, mixing, combination, and 2D and 3D arrangement of liquids, biological compounds, cell solutions, hydrogels, hydrogels loaded with cells, bioceramics, bioplastics, base materials for micro and nano particles; cartridges for containing printing material for use with 3D printers, sold empty; cartridges for containing bioprinting materials for use with 3D bioprinters, sold empty; printing cartridges for containing biological materials for use with 3D printers and bioprinters, sold empty; printing cartridges for containing ink for 3D printing of biological tissues and organs; tools and accessories for manufacturing and producing biological tissues, especially for observation, measuring, handling, stimulation or modification of biological tissues, tissue compositions, cell aggregates and cells, namely, 3D printers, and thermal control being block type thermal power stations for power generation | ACTIVE | — |
| 009 | laboratory apparatus and instruments, including accessories, namely, bioreactors, for cell culturing; laboratory apparatus and instruments for engineering biological tissues, tissue compositions, cell aggregates and cells, namely, laboratory apparatus and instruments for the design, engineering and maintenance of biological tissues, tissue compositions, cell aggregates and cells; laboratory robots that can be used in biotechnology and in the field of pharmaceutical and cosmetic products; 2D and 3D scanners in the field of additive manufacturing processes and applications; optical apparatus and instruments, namely, cameras, microscopes, laser measuring systems, calibration apparatus for calibrating electric microvalves, and measurement apparatus being temperature indicators, flowmeters, distance measuring apparatus, calipers, all in the field of additive manufacturing processes and applications; optical readers and optical inspection apparatus in the field of additive manufacturing processes and applications; laboratory tools and accessories for the manufacture and production of biological tissues, especially for observation, measurement, handling, stimulation or modification of biological tissues, tissue compositions, cell aggregates and cells, namely, cameras, electric sensors, optical profilers, electrical transducers, thermal control being thermal printers, downloadable software and pre-installed software for 2D and 3D design for the definition and management of manufacturing and production processes for biological tissues or organs, medical implants and pharmaceuticals; downloadable software and pre-installed software for the operation and control of machines, instruments and apparatus intended for engineering, manufacturing and producing biological tissues, tissue compositions, cell aggregates, cells, organs, medical implants or pharmaceuticals; downloadable software and pre-installed software for the operation and control of devices being used in biotechnology and in the pharmaceutical and cosmetic industries for computer-aided three-dimensional dosing of biomaterials for biofunctional shaping of cell carrier structures, tissues, blood vessels, implants, prostheses and drug delivery systems; downloadable software and pre-installed software used for 3D design, 3D printing and 3D manufacturing; downloadable software and pre-installed software for image processing and medical image processing | ACTIVE | — |
| 010 | Non-biological implants being surgical implant comprised of artificial materials produced by additive manufacturing intended for surgical and orthopedic purposes; dental crowns, incrustations being dental inlays and onlays and dental implants made by additive manufacturing; artificial implants and transplants being implants comprising natural, non-living material intended for replacing and/or supporting the function of missing or damaged body parts; surgical apparatus and instruments involving the extrusion, dosing or manufacture of biological tissues, tissue arrays, cell aggregates and cells, namely, surgical robots and surgical instruments; surgical and medical devices for use in situ bioprinting, namely, surgical robots and surgical instruments | ACTIVE | — |
| 041 | Training and education services in the nature of workshops, seminars, non-downloadable webinars, and conferences in the field of bioprinting and biomanufacturing | ACTIVE | — |
| 042 | Scientific services, namely, conducting technical project studies in the nature of conducting scientific feasibility studies in the field of additive manufacturing, technological research in the field of additive manufacturing, research and development of new products for others in the field of additive manufacturing; research and development in the field of additive manufacturing; scientific services in connection with the design, development and support of software, namely, conducting technical project studies in the nature of conducting scientific feasibility studies, computer software consultancy, computer software design, research and development of new products for others; advice and information concerning additive manufacturing research and development and software design and development | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by regenHU AG
- Other trademarks owned by regenHU AG
- Other trademarks owned by regenHU AG
- Other trademarks in Class 001
- Other trademarks in Class 005
- Other trademarks in Class 007
- Other trademarks in Class 009
- Other trademarks in Class 010
- Other trademarks in Class 041
- Other trademarks in Class 042
- Similar marks named REGENHU
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Dec 4, 2025 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Dec 3, 2023 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Nov 15, 2023 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Nov 15, 2023 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Nov 15, 2023 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Aug 15, 2023 | NRCC | NOTICE OF REGISTRATION CONFIRMATION EMAILED | — |
| Aug 15, 2023 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| May 30, 2023 | GPNX | NOTIFICATION PROCESSED BY IB | — |
| May 30, 2023 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| May 30, 2023 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| May 10, 2023 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| May 10, 2023 | OP2R | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | — |
| May 10, 2023 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Apr 26, 2023 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Apr 25, 2023 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Apr 25, 2023 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Apr 25, 2023 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Apr 25, 2023 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Mar 29, 2023 | OPNX | NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB | — |
| Mar 8, 2023 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Mar 8, 2023 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Mar 8, 2023 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Mar 8, 2023 | ERFR | TEAS REQUEST FOR RECONSIDERATION RECEIVED | — |
| Mar 8, 2023 | OPNR | NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB | — |
| Dec 18, 2022 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Sep 8, 2022 | GNFN | NOTIFICATION OF FINAL REFUSAL EMAILED | — |
| Sep 8, 2022 | GNFR | FINAL REFUSAL E-MAILED | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Sep 8, 2022 | CNFR | FINAL REFUSAL WRITTEN | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Aug 3, 2022 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Aug 2, 2022 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Aug 2, 2022 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jun 10, 2022 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Feb 20, 2022 | RFNT | REFUSAL PROCESSED BY IB | — |
| Feb 2, 2022 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Feb 2, 2022 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Jan 12, 2022 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Jan 11, 2022 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jan 3, 2022 | DOCK | ASSIGNED TO EXAMINER | — |
| Oct 16, 2021 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Oct 12, 2021 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Oct 8, 2021 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |